MX359974B - Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer. - Google Patents

Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer.

Info

Publication number
MX359974B
MX359974B MX2014003941A MX2014003941A MX359974B MX 359974 B MX359974 B MX 359974B MX 2014003941 A MX2014003941 A MX 2014003941A MX 2014003941 A MX2014003941 A MX 2014003941A MX 359974 B MX359974 B MX 359974B
Authority
MX
Mexico
Prior art keywords
preventing
caffeic acid
treating cancer
phenethyl ester
acid phenethyl
Prior art date
Application number
MX2014003941A
Other languages
English (en)
Other versions
MX2014003941A (es
Inventor
Ramón Ángeles Anguiano Enrique
María Velázquez Sánchez Ana
Hugo Vázquez Valadez Víctor
Hugo Abrego Reyes Víctor
Arturo Martínez Soriano Pablo
Romero Rojas Andrés
Díaz Barriga Arceo Sandra
Del Carmen Camacho Enríquez Brígida
Dueñas González Alfonso
Villa Treviño Saúl
Basset Ruiz Sánchez Mónica
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2014003941A priority Critical patent/MX359974B/es
Priority to PCT/IB2015/052297 priority patent/WO2015151005A2/es
Publication of MX2014003941A publication Critical patent/MX2014003941A/es
Publication of MX359974B publication Critical patent/MX359974B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/13—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere específicamente a la síntesis química, identificación y determinación de la estructura química de compuestos con actividad contra cáncer, en particular cáncer hepático de compuestos análogos del éster fenetílico del ácido caféico (CAPE) definimos tres fórmulésteras generales. La invención también se refiere a la preparación de composiciones farmacéuticas y al uso de los compuestos descritos en la prevención y el tratamiento del cáncer por su capacidad quimioprotectora.
MX2014003941A 2014-04-01 2014-04-01 Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer. MX359974B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2014003941A MX359974B (es) 2014-04-01 2014-04-01 Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer.
PCT/IB2015/052297 WO2015151005A2 (es) 2014-04-01 2015-03-28 Compuestos análogos del éster fenetílico del ácido caféico y su uso para la prevención y tratamiento de cáncer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014003941A MX359974B (es) 2014-04-01 2014-04-01 Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer.

Publications (2)

Publication Number Publication Date
MX2014003941A MX2014003941A (es) 2015-09-30
MX359974B true MX359974B (es) 2018-10-05

Family

ID=54241390

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003941A MX359974B (es) 2014-04-01 2014-04-01 Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer.

Country Status (2)

Country Link
MX (1) MX359974B (es)
WO (1) WO2015151005A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4276089A3 (en) 2016-03-03 2023-12-20 Universite De Moncton Modulators of lipoxygenase and cyclooxygenase enzyme activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2648003C (en) * 2006-03-31 2014-07-08 The Board Of Regents Of The University Of Texas System Orally bioavailable caffeic acid related anticancer drugs

Also Published As

Publication number Publication date
MX2014003941A (es) 2015-09-30
WO2015151005A3 (es) 2016-01-07
WO2015151005A2 (es) 2015-10-08

Similar Documents

Publication Publication Date Title
PH12017502255A1 (en) Nrf2 regulators
PH12016501151A1 (en) Nrf2 regulators
EA201691857A1 (ru) Соединения, применимые в качестве иммуномодуляторов
PH12016501578A1 (en) Pharmaceutical compounds
PH12017500745A1 (en) Bromodomain inhibitors
PH12016500225A1 (en) Novel quinoline-substituted compound
MX2017008136A (es) Sal de l-tartrato de pridopidina.
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
PH12016501462A1 (en) Neprilysin inhibitors
EA201692548A1 (ru) Минеральные аминокислотные комплексы активных веществ
IL246655B (en) A medical preparation containing a pyridyl amino acetic acid compound
IL250882A0 (en) A new pharmaceutical compound containing a hydroxamic acid derivative or a salt thereof
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
MX2022006304A (es) Composiciones y metodos para inhibir la actividad biologica de biomoleculas solubles.
MX2017007377A (es) Compuestos organicos.
MX2018000264A (es) Formulaciones topicas de diacereina de rheina y sus usos.
EA201500821A1 (ru) Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов
PL3164116T3 (pl) Kompozycje musujące zawierające kokryształy części kwasowej
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
MX371158B (es) Compuestos inhibidores de pde2.
MX2014003941A (es) Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer.
EP3121167A4 (en) Compound binding to pparg but not acting as promoter and pharmaceutical composition for treating pparg-related diseases containing same as active ingredient
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
EA033077B1 (ru) Фармацевтическая композиция, содержащая 13 глицеридов, и ее препараты и их применение
RS20150238A1 (en) (S) -2-AMINO-3-CYCLOHEXYLPROPANIC ACID DERIVATIVES, THEIR PRODUCTION AND USE

Legal Events

Date Code Title Description
FG Grant or registration